Pharmafile Logo
Pharmafocus logo
Advanced Search

BMS

Showing 15 posts of 287 posts found.

screen_shot_2014-06-11_at_14

Bristol-Myers Squibb hires new general manager





June 11, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amadou Diarra, BMS, Bristol-Myers Squibb, Johanna Mercier

Johanna Mercier has been appointed as Bristol-Myers Squibb’s general manager for the UK and Ireland.  The appointment of Mercier who …

Appointment

GSK signs Adaptimmune deal

June 3, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AZ, Adaptimmune, BMS, Cancer, GSK, oncology

GlaxoSmithKline has signed a deal to develop and commercialise biotech firm Adaptimmune’s lead clinical cancer programme with T-cell receptors (TCRs), …

News
tim_whitten

Taiho hires head from BMS

May 29, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, taiho, whiten

Japan-based pharma firm Taiho Oncology has appointed Tim Whitten to the position of senior vice president and chief commercial officer. …

Appointment
BMS image

BMS signs cancer deal

May 28, 2014
Research and Development, Sales and Marketing ASCO, AstraZeneca, BMS, Cancer, Merck, Roche, cytomx, oncology

Bristol-Myers Squibb has partnered with CytomX Therapeutics to discover and develop new immuno-oncology candidates using the latter’s Probody Platform technology. …

News
bms_close_logo

BMS and AbbVie get FDA lift

May 21, 2014
Research and Development, Sales and Marketing AbbVie, BMS, FDA, elotuzumab, multiple, myeloma

Bristol-Myers Squibb and AbbVie are celebrating after receiving breakthrough designation status from the US regulator for their investigational medicine elotuzumab …

News

ASCO 2014: Cancer immune therapy race heats up

May 15, 2014
2014, ASCO, AZ, BMS, Cancer, Merck, Roche, chicago

A number of major players in oncology are set to showcase rival immunotherapy data at this year’s American Society of …

News
Samsung Incheon plant image

BMS expands Samsung deal

April 29, 2014
Manufacturing and Production BMS, Roche, Samsung, UCSF, biologics, incheon

Bristol-Myers Squibb has expanded its biopharmaceutical manufacturing agreement with South Korea’s Samsung BioLogics. Last year, Bristol-Myers Squibb signed a 10-year …

News
Astrazeneca image

Profits slump at AstraZeneca

April 24, 2014
Sales and Marketing AZD9291, AstraZeneca, BMS, Brilinta, Q1

AstraZeneca has continued its poor run of form, with operating profit in the first quarter of 2014 falling 40% on …

News
BMS image

BMS hopes for Yervoy sequel with new deal

March 18, 2014
Research and Development, Sales and Marketing Avapro, BMS, Plavix, Yervoy, five prime, immune-oncology

Bristol-Myers Squibb has announced a new research and development deal with Five Prime Therapeutics aimed at discovering potentially new cancer …

News
BMS site image

160 jobs in peril at BMS Ireland plant

March 7, 2014
Manufacturing and Production, Sales and Marketing BMS, Cruiserath, Dublin, Ireland, swords

Bristol-Myers Squibb will close its Dublin manufacturing facility at Cruiserath in Ireland by the end of 2015 the firm has …

News
BMS image

BMS/AZ fat disorder drug gains FDA approval

February 26, 2014
Research and Development, Sales and Marketing AstraZeneca, BMS, FDA, hep C, metreleptin, myalept

Bristol-Myers Squibb and partner AstraZeneca have been granted FDA approval for a new drug to treat rare and potentially fatal …

News
Yervoy image

NICE restricts Yervoy use

February 25, 2014
Sales and Marketing BMS, Cancer, NHS, NICE, Yervoy, melanoma

Bristol-Myers Squibb has been dealt a blow by NICE after the UK cost watchdog recommended that the use of skin …

News
Astrazeneca image

AstraZeneca ‘simplifies decision-making’

February 4, 2014
Sales and Marketing AstraZeneca, BMS, Byetta, Forxiga, Onglyza, diabetes

AstraZeneca has completed its $4.3 billion acquisition of Bristol-Myers Squibb’s diabetes business, giving the company control over several big-name brands …

News
BMS image

BMS revenue drops in 2013

January 27, 2014
Sales and Marketing AZ, BMS, Yervoy, diabetes, hep C, q4

Bristol-Myers’ Squibb’s revenue has fallen 7% year-on-year to $16.4 billion during 2013. Turnover rose 6% to $4.4 billion in the …

News
forxiga image

FDA approves Farxiga

January 10, 2014
Sales and Marketing AstraZeneca, BMS, FDA, Forxiga, diabetes

The FDA has approved Farxiga, the diabetes treatment developed by AstraZeneca and Bristol-Myers Squibb as part of their soon-to-be-defunct diabetes …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026